Contrast-enhanced MRI reliably predicts whether acute stroke patients receiving intravenous tPA treatment are particularly susceptible to intracranial hemorrhage, according to a study presented Monday at the American Society of Neuroradiology meeting in San Diego.
Contrast-enhanced MRI reliably predicts whether acute stroke patients receiving intravenous tPA treatment are particularly susceptible to intracranial hemorrhage, according to a study presented Monday at the American Society of Neuroradiology meeting in San Diego.
Dr. David J. Mikulis, an associate professor of neuroradiology at Toronto Western Hospital, reported that the presence of blood-brain barrier breakdown identified with postgadolinium T1-weighted spin-echo imaging produced 100% positive and negative predictive values for 10 of 24 patients who developed hemorrhagic transformation.
Hyperintensities were absent in all 14 patients without intracranial bleeding but were seen in five of 10 patients who developed hemorrhage in the week following treatment.
"Basically, if you don't bleed, we don't see these signs," Mikulis said.
The imaging protocol involved three gadolinium injections to measure permeability, perfusion, and vascular occlusion with CE-MR angiography. A T1-weighted axial sequence determined the degree of enhancement in the middle cerebral artery region.
As a screening tool, the technique promises to reduce the risk of intracranial bleeding among stroke patients who receive tPA thrombolysis. Although tPA can reverse the neurological deficits of stroke, it also increases risk of hemorrhagic transformation 10-fold, Mikulis said.
Studies presented by Mikulis and other researchers at the meeting added weight to growing evidence demonstrating the power of MRI and CT to determine when tPA thrombolysis should be attempted beyond the traditional three-hour treatment window.
Previous research suggested that microbleeds could serve as markers of risk for hemorrhagic transformation, but evidence accumulated by Dr. Eliana E. Bonfante and Dr. Karen C. Albright at the University of Texas in Houston found no significant correlation between microbleeding and the incidence of hemorrhagic conversion after thrombolytic therapy.
Dr. Max Wintermark, an assistant professor of radiology at the University of California, San Francisco, was one of several neuroradiologists who presented evidence showing equivalence between perfusion CT and diffusion-perfusion MRI for identifying salvageable brain tissue to help select patients for intra-arterial thrombolysis three to nine hours after the onset of stroke symptoms.
Excellent agreement between the two techniques was seen among 45 patients for determining the extent of cortical involvement, calculating penumbra size, and identifying 14 patients for intra-arterial tPA treatment. Only one patient who would have been treated on the basis of the MRI evaluation would not have received thrombolysis on the basis of the functional CT and CTA studies.
Noncontrast CT is routinely used to discriminate between hemorrhagic and ischemic stroke, so add-on perfusion CT could offer a convenient way to measure the presence and extent of salvageable brain tissue.
Dr. Pamela Schaefer, an associate professor of neuroradiology at Massachusetts General Hospital, presented research showing the diagnostic power of a faster and easier MR method for isolating ischemic penumbra. The MGH study of 44 patients found the five-minute enhancement mapping technique performs as well as methods using time-consuming deconvolution-based algorithms.
Based on DWI-PWI mismatch criteria, readers came up with the same decision whether to administer intra-arterial tPA in 36 of 44 patients (images were uninterpretable in two cases, and in two other cases, the perfusion deficits were almost exactly 20% larger than the diffusion deficits, making decision making difficult). Among these 36 studies, the sensitivity and specificity of MTE maps for detecting mismatch were 87% and 85%, respectively, for reader one and 93% and 95%, respectively, for reader two.
For more information from the Diagnostic Imaging archives:
The window expands for more effective stroke treatment
Aggressive tPA stroke treatment promises to lower long-term costs
Seventh measurement can increase six-stroke parameter sensitivity
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
New Survey Explores Radiologist and Neurologist Comfort Level with AI Triage for Brain MRI
January 7th 2025Survey results revealed that 71 percent of clinicians preferred adjunctive AI in facilitating triage of brain MRI scans and 58 percent were comfortable utilizing AI triage without input from radiologists.